Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2019 2020 2021 2022 2023 2024 2025
Months
January February March April May June July August September October November December
Previous Archive
15 July 2022 | Story Lacea Loader

The Council of the University of the Free State (UFS) approved the lifting of the institution’s COVID-19 Regulations and Required Vaccination Policy with immediate effect.

“Since the declaration by the Government on 22 June 2022 that the COVID-19 regulations will be repealed, the UFS has conducted a risk assessment to determine the risk of exposure to staff and students. From the assessment, it was clear that the university’s COVID-19 infections are currently a low risk,” said Prof Francis Petersen, Rector and Vice-Chancellor of the UFS.

Factors that contributed to this low risk include the following:

  • No COVID-19 positive cases among UFS staff and students have been reported in the past month.
  • The high number of vaccinations among UFS stakeholders. In addition, the current national immunity level of the total South African population is high.
  • Certain faculties and postgraduate students are currently proceeding with hybrid/online learning, which minimises the risk of possible COVID-19 infections on the university’s three campuses.
  • In its correspondence of 23 June 2022, the UFS urged all staff and students to continue wearing masks should they have comorbidities and/or symptoms of illness, thus safeguarding other stakeholders.

“We believe that COVID-19 no longer poses an immediate threat to the safety of our staff and students, and that the pandemic is at a stage where they should take responsibility for their own safety. This can be mainly ascribed to the success of the implementation of the policy. Staff and students who still wish to wear masks are urged to do so at their own discretion. Those who have not yet been vaccinated against the virus and have no

known condition preventing them from doing so, are advised to get vaccinated for their own safety and protection,” said Prof Petersen.

The UFS COVID-19 Regulations and Required Vaccination Policy was approved by the University Council on 26 November 2021 and implemented on 6 December 2021. The university commenced restricting unvaccinated individuals from accessing its campuses as of 14 February 2022.

“If the national regulatory environment with respect to COVID-19 is changing to such an extent that the policy needs to be re-implemented, the university’s executive management will act accordingly, and hence the COVID-19 Regulations and Required Vaccination Policy remains a policy of the university as approved by the UFS Council on 26 November 2021.” said Prof Petersen.

 

Uplifting of the COVID-19 vaccination policy - mitigation strategies of the University of the Free State.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept